Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8Sarcoma 1CNS 1Breast 1

Conditions

Breast Neoplasms 74Carcinoma, Intraductal, Noninfiltrating 11Breast Carcinoma In Situ 9Breast Neoplasms, Male 8Carcinoma, Ductal, Breast 5Inflammatory Breast Neoplasms 4Depression 3Carcinoma, Lobular 3Triple Negative Breast Neoplasms 2Radiation Injuries 2Colorectal Neoplasms 2Colonic Neoplasms 2Skin Abnormalities 1Recurrence 1Pain 1Paget's Disease, Mammary 1Neoplasm Metastasis 1Melanoma 1Malnutrition 1Infertility 1Hot Flashes 1HER2 Negative Breast Cancer 1Fatigue 1Endometrial Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Cardiotoxicity 1

Interventions

Paclitaxel 50Capecitabine 50Trastuzumab 38Fulvestrant 31pembrolizumab 27Cyclophosphamide 27Carboplatin 27Gemcitabine 23Letrozole 21palbociclib 19Docetaxel 19Lapatinib 18Bevacizumab 18exemestane 17eribulin 15Everolimus 14abemaciclib 13Vinorelbine 13Nivolumab 13Magnetic Resonance Spectroscopy 12Cisplatin 12Anastrozole 12trastuzumab deruxtecan 11Zoledronic Acid 11Doxorubicin 11Albumin-Bound Paclitaxel 11olaparib 10Tamoxifen 10Specimen Handling 10Radiotherapy 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Chemotherapy, Adjuvant × Breast × Clear all
NCT00072020 2013-08-02

Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡